Navigation Links
Scientists, physicians present latest findings in 'personalized' cancer treatment and prevention

PHILADELPHIA Scientists and clinicians from around the world will gather in Atlanta, Georgia next week at the American Association for Cancer Researchs second International Conference on Molecular Diagnostics in Cancer Therapeutic Development. The conference is subtitled Maximizing Opportunities for Personalized Treatment, which reflects the potential of molecular diagnostics to provide new strategies for tailoring therapies to fit the needs of each cancer patients unique biology.

Sessions will include discussions on the use of biomarkers blood-borne molecules that indicate the presence of cancer in clinical practice and new drug development, advanced imaging technologies for diagnosis, and the application of proteomics in personalized medicine. Novel findings to be reported at the conference include:

  • Case studies that report how clinicians are already bridging the gap between basic cancer biology and personalized clinical care. Researchers present examples of how they fine-tuned the treatment of a number of different cancer types, including lung and ovarian, based on the genetic profile of the patients tumors.

  • A new acoustic sensor device that could make it possible to screen for multiple cancer biomarkers during a routine doctors visit.

  • A sensitive blood test for early-stage liver cancer that detects a gene altered by the molecular processes that lead to cancer.

  • A blood-borne protein, present in 99 percent of lung cancer patients tested, could provide a target for a simple blood test for the disease.

As genetic, proteomic, imaging, and other new technologies become more sophisticated and our knowledge of tumor biology and signaling pathways advances, so too does our ability to molecularly characterize individual tumors and identify germline determinants of patient prognosis and response, said David Sidransky, M.D., meeting chairperson and professor of Otolaryngology - Head and Neck Surgery, Oncology, Pathology, Urology, and Cellular and Molecular Medicine at Johns Hopkins University School of Medicine and director, Head and Neck Cancer Research at The Johns Hopkins Hospital.

This new era of personalized medicine has brought with it great opportunities to enhance cancer drug development and improve patient care, Dr. Sidransky said. However, in order to harness this potential and maximize these opportunities, it is essential that there be an ongoing exchange of new ideas and information.

In addition to symposia and poster sessions, the conference will include a keynote lecture by Victor E. Velculescu, M.D., Ph.D., assistant professor in the Department of Oncology at Johns Hopkins Universitys Sidney Kimmel Comprehensive Cancer Center. Dr. Velculescu, a cancer genetics researcher, presents an address entitled Blueprint of the Breast and Colorectal Cancer Genomes.


Contact: Greg Lester
American Association for Cancer Research

Related medicine news :

1. Male Contraception: Discovery Stirring Interest Among Scientists, Drug Developers
2. Startling Expose – Physicians Often Have No Regular Source Of Health Car
3. IMA to create database on physicians
4. "Make AIDS Therapy affordable" - Physicians demand
5. Physicians Consider Self-Prescribing Ethical
6. Guide for physicians launched to help them identify alcohol disorders
7. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
8. Physicians Need To Treat Patients With Respect For Treatment To Be Effective
9. Resident Physicians Need More Preparations To Treat Patients From Different Cultures
10. Physicians To Discuss Ways To Save Premature Babies From RSV
11. Physicians should encourage US women to breastfeed
Post Your Comments:
(Date:6/27/2016)... ... , ... recently awarded their highest five-star rating to Best Buy Eyeglasses, ... the United States and Canada wear eyeglasses. Once considered to be a purely functional ... a fashion statement. Even celebrities use glasses as a way of creating an iconic ...
(Date:6/26/2016)... Cary, North Carolina (PRWEB) , ... June 26, 2016 , ... ... the release of a new product that was developed to enhance the health of ... harvested for centuries. , The two main herbs in the PawPaws Cat Kidney ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
Breaking Medicine Technology: